KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardlytics (CDLX) Payables (2017 - 2026)

Cardlytics filings provide 10 years of Payables readings, the most recent being $2.6 million for Q1 2026.

  • Quarterly Payables fell 94.84% to $2.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $2.6 million through Mar 2026, down 94.84% year-over-year, with the annual reading at $2.7 million for FY2025, 94.64% down from the prior year.
  • Payables hit $2.6 million in Q1 2026 for Cardlytics, down from $2.7 million in the prior quarter.
  • Across five years, Payables topped out at $50.4 million in Q1 2025 and bottomed at $2.1 million in Q1 2023.
  • Average Payables over 5 years is $20.5 million, with a median of $4.8 million recorded in 2022.
  • The largest annual shift saw Payables skyrocketed 1167.77% in 2025 before it tumbled 94.84% in 2026.
  • Cardlytics' Payables stood at $3.8 million in 2022, then increased by 17.53% to $4.4 million in 2023, then surged by 1019.82% to $49.6 million in 2024, then tumbled by 94.64% to $2.7 million in 2025, then decreased by 2.07% to $2.6 million in 2026.
  • Per Business Quant, the three most recent readings for CDLX's Payables are $2.6 million (Q1 2026), $2.7 million (Q4 2025), and $49.7 million (Q3 2025).